Vanguard Group
TSRX

Vanguard Group’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Vanguard Group’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-659,415
Closed -$5.36M – 3856
2013
Q2 		$5.36M Buy
+659,415
New +$4.87M ﹤0.01% 2624

Other funds holding TSRX

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Vanguard Group's TSRX Position: Q3 2013 in Review

Vanguard Group sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 659,415 shares — an estimated $5.36M sold.

Vanguard Group first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $5.36M in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

  • Vanguard Group reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • Vanguard Group sold 659,415 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $5.36M.
  • Vanguard Group first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • Vanguard Group's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $5.36M in Q2 2013.
  • 7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Vanguard Group's 13F filing for Q3 2013, filed 7 Nov 2013.